Literature DB >> 19473995

Job strain and symptoms of angina pectoris among British and Finnish middle-aged employees.

T Lallukka1, T Chandola, H Hemingway, M Marmot, E Lahelma, O Rahkonen.   

Abstract

BACKGROUND: High job strain has been linked with cardiovascular outcomes. This study aimed to examine whether job strain is associated with angina pectoris symptoms among British and Finnish non-manual employees.
METHODS: Postal questionnaire survey data among 40-60-year-old employees of the British Whitehall II Study (n = 4551, 27% women) and the Finnish Helsinki Health Study (n = 7605, 83% women) cohort were analysed. Angina pectoris symptoms were the outcome in logistic regression analysis. Karasek's job strain was examined. Models were adjusted first for age, second for occupational class and finally for smoking, heavy drinking, physical inactivity, unhealthy food habits and obesity.
RESULTS: Angina pectoris symptoms were reported by 5% of women and 3% of men in Britain, and by 6% of women and 4% of men in Finland. High job strain was associated with angina pectoris symptoms among men in Britain (OR 2.08; CI 95% 1.07 to 4.02) and women in Finland (OR 1.90; CI 95% 1.36 to 2.63) independent of age, occupational class, and behavioural risk factors. However, similar associations between job strain and angina pectoris symptoms were not observed among men in Finland or women in Britain.
CONCLUSION: The results yielded partial support for the association between job strain and angina pectoris symptoms across national contexts.

Entities:  

Mesh:

Year:  2009        PMID: 19473995     DOI: 10.1136/jech.2008.085878

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  1 in total

1.  Job stress across gender: the importance of emotional and intellectual demands and social support in women.

Authors:  Pilar Rivera-Torres; Rafael Angel Araque-Padilla; María José Montero-Simó
Journal:  Int J Environ Res Public Health       Date:  2013-01-14       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.